Caris Life Sciences (CAI) Other Operating Expenses (2024 - 2026)

Caris Life Sciences' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $119.9 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 15.61% year-over-year to $119.9 million; the TTM figure through Mar 2026 stood at $456.6 million (up 15.41% YoY), while the FY2025 annual figure was $440.4 million, up 14.06% from the prior year.
• Other Operating Expenses was $119.9 million for Q1 2026 at Caris Life Sciences, up from $116.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $119.9 million in Q1 2026 to a low of $94.0 million in Q3 2024.
• Historically, Other Operating Expenses has averaged $106.5 million across 3 years, with a median of $106.8 million in 2025.
• Biggest YoY gain for Other Operating Expenses was 20.04% in 2025; the steepest drop was 8.66% in 2025.
• A 3-year view of Other Operating Expenses shows it stood at $96.7 million in 2024, then rose by 20.04% to $116.1 million in 2025, then climbed by 3.23% to $119.9 million in 2026.
• The last three Other Operating Expenses figures came in at $119.9 million (Q1 2026), $116.1 million (Q4 2025), and $110.6 million (Q3 2025), per Business Quant data.